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Abstract
Background: Staging of melanoma includes quantification of a proliferation index, i.e., presumed melanocytic
mitoses of H&E stains are counted manually in hot spots. Yet, its reproducibility and prognostic impact increases
by immunohistochemical dual staining for phosphohistone H3 (PHH3) and MART1, which also may enable fully
automated quantification by image analysis. To ensure manageable workloads and repeatable measurements in
modern pathology, the study aimed to present an automated quantification of proliferation with automated hot-spot
selection in PHH3/MART1-stained melanomas.
Methods: Formalin-fixed, paraffin-embedded tissue from 153 consecutive stage I/II melanoma patients was
immunohistochemically dual-stained for PHH3 and MART1. Whole slide images were captured, and the number
of PHH3/MART1-positive cells was manually and automatically counted in the global tumor area and in a manually and
automatically selected hot spot, i.e., a fixed 1-mm2 square. Bland-Altman plots and hypothesis tests compared manual
and automated procedures, and the Cox proportional hazards model established their prognostic impact.
Results: The mean difference between manual and automated global counts was 2.9 cells/mm2 (P = 0.0071) and 0.23
cells per hot spot (P = 0.96) for automated counts in manually and automatically selected hot spots. In 77 % of cases,
manual and automated hot spots overlapped. Fully manual hot-spot counts yielded the highest prognostic performance
with an adjusted hazard ratio of 5.5 (95 % CI, 1.3–24, P = 0.024) as opposed to 1.3 (95 % CI, 0.61–2.9, P = 0.47) for
automated counts with automated hot spots.
Conclusions: The automated index and automated hot-spot selection were highly correlated to their manual
counterpart, but altogether their prognostic impact was noticeably reduced. Because correct recognition of only
one PHH3/MART1-positive cell seems important, extremely high sensitivity and specificity of the algorithm is
required for prognostic purposes. Thus, automated analysis may still aid and improve the pathologists’ detection
of mitoses in melanoma and possibly other malignancies.
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Background
The mitotic index of thin primary melanomas (≤1 mm)
was included in the Cancer Staging Manual of the
American Joint Committee on Cancer in 2010 [1]. Its
recommended quantification in hot spots (1 mm2 with
most mitoses) by microscopy of H&E stains [2] is, how-
ever, very laborious and associated with low intra and
interobserver variability [3–6]. Henceforth, prognostic
impact of the alternate immunohistochemical prolifera-
tion markers Ki67 and phosphohistone H3 (PHH3) have
been widely studied [7–12]. Because they both label all
types of proliferating cells, recent studies demonstrate
great utility of immunohistochemical double stains that
combine Ki67 or PHH3 with the melanocytic marker
MART1 [6, 10, 12–14]. This enables definite distinction
of proliferative melanocytic cells and, e.g., proliferative
lymphocytes or endothelial cells.
In accordance with a similar study of nodular melan-
oma [8], we recently demonstrated that proliferation
measured by PHH3/MART1 stains was a much stronger
prognostic marker than both Ki67/MART1 and H&E
stains in stage I/II melanoma. Moreover, quantification
in hot spots was highly superior to quantification in the
global tumor area for prognostic purposes [10]. Even
though PHH3/MART1 eased the detection of tumor-cell
proliferation substantially compared with H&E, man-
ual counting and hunts for a single mitosis were still
very cumbersome and time-consuming, and hot-spot
selection somewhat subjective. To ensure a manage-
able workload and repeatable measurements in mod-
ern pathology, fully automated quantification including
automated hot-spot selection by image analysis seems
favorable.
To date, automated quantification of PHH3 single
stains has only been reported for the global tumor area
in a few malignancies, predominantly breast cancer [15,
16], and very recently for manually selected hot spots in
melanoma [11]. Surprisingly, we found no studies evalu-
ating the agreement between manual and automated
PHH3 counts, merely their association [17]. Algorithms
for automated hot-spot selection are, so far, only re-
ported for Ki67 single stains in adrenal cortical cancer
[18], ovarian adenocarcinoma [19], and glioma [20].
Seemingly, all remain untested in context to their clin-
ical purpose. Double stains may, nevertheless, increase
accuracy of both automated PHH3 quantification and
automated hot-spot selection; especially in melanoma
that often contains a prominent lymphatic infiltrate with
many proliferative lymphocytes. In addition, double stains
enable calculation of various new index types, e.g., based
on the exact area of melanocytic cells, rather than just the
previously reported number per outlined area. Thus,
cellular density that may vary considerably per unit area
may more easily be incorporated.
This study aims to present the most optimal quantifi-
cation of tumor-cell proliferation in PHH3/MART1-
stained melanomas. Both manual and fully automated




Formalin-fixed, paraffin-embedded tissue from 153 pri-
mary cutaneous melanomas from the Departments of
Pathology at Aarhus University Hospital and Randers
Hospital, Denmark, were included [10]. The patient char-
acteristics of this previously described prospective patient
cohort with consecutive stage I/II patients from 1997 to
2000 are presented in Table 1. The median Breslow thick-
ness was 1.20 mm (range, 0.24–16 mm) and median age
51 years (range, 23–79 years). Recurrent disease accoured
in 43 patients (28 %), in which, three were thin melanoma.
The median follow-up time was 12 years (range, 8–14
years) for patients with event-free melanoma [10, 21].
Prior to start, the Central Denmark Region Committee
on Biomedical Research Ethics approved the study.
Immunohistochemistry
BenchMark XT (Ventana Medical Systems, Inc., Tuc-
son, AZ, USA) performed new PHH3/MART1 stains
on 3-μm sections because stains of former study were
inadequate for image analysis due to both very weak
and dark MART1 staining [10]. In short, polyclonal rabbit
antibody Phospho-Histone H3 (Ser10; 1:300; 32 min; Cell
Signaling Technology, Inc., Danvers, MA, USA) and mono-
clonal mouse antibody MART-1 (M2-7C710, 1:50; 40 min;
Table 1 Patient characteristics
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Cell Marque Corporation, Rocklin, CA) were applied in
sequence and visualized by Ventanas Detection Kits:
ultraView Universal 3,3’-Diaminobenzidin (DAB) and
ultraView Universal Alkaline Phosphatase Red. Positive
controls were included. Slides were counterstained with
Mayer’s hematoxylin and bluing reagent.
Scanning
Whole slide images were captured by Nanozoomer
2.0HT (Hamamatsu Phototonics K.K., Hamamatsu City,
Japan) at magnification 20X (Fig. 1a-c).
Manual quantification
The global dermal tumor area (Fig. 1a) was outlined
manually in Visiopharm Integrator System 5.0.1.1122
(Visiopharm A/S, Hørsholm, Denmark). PHH3/MART1-
positive cells, defined as nuclei more brown than blue
with noticeable MART1 surrounding (Fig. 1c), were
counted manually at optical magnification 40X within
the global outline and in a manually selected hot spot,
i.e., a fixed 1-mm2 square where epidermal regions and
skin adnexa were omitted (Fig. 1g), if necessary. Previous
comparison of one big 1-mm2 hot spot versus four small
adjoining 0.25-mm2 hot spots within dermis (similar to
the conventional method) revealed no distinct difference
in their prognostic impact [10]. All manual procedures
were performed without knowledge of patient outcome.
Automated quantification
In the Visiomorph DP module (Visiopharm), the brown,
blue, and red staining colors were highlighted by color
deconvolution, in which a standard deviation filter fur-
ther enhanced the contours of PHH3-positive nuclei. In
addition, the intensity band of the HSI (hue, saturation,
intensity) color model highlighted PHH3 positivity.
Thresholding functions partitioned the image into the
image classes brown PHH3, red MART1, and blue
hematoxylin. In addition to color intensity, post-processing
algorithms further highlighted PHH3-positive and PHH3-






Fig. 1 Superficial spreading melanoma stained for PHH3/MART1. a Manual outline of global tumor (yellow line). b-c PHH3/MART1-positive cells
with further display of cells in late G2 and M: prophase, metaphase, anaphase, and telophase. d-e Automated analysis within outline; MART1-verified tumor
area includes orange and blue labels of MART1 and nuclei, respectively. f Area within global tumor outline. g Manual hot spot excluding
epidermis. h Automated heat map. i Automated hot spot.
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intensity, and nuclear irregularity. One particular step
included dilation of PHH3; hence, cromatin of especially
the anaphase and telophase was fused into one object. Blue
nuclei of PHH3-negative melanocytic cells were lastly chan-
ged into the image class MART1 (Fig. 1d-f), because the
reference space was defined as MART1-verified tumor area
including nuclei.
Based on the labels of image analysis, a hot spot was
automatically detected using the processing step Object
Heat Map, in which circles identify and cover the object
of interest to produce a heat map according to their clus-
ter (Fig. 1h). Accordingly, the center of a circle (radius,
200 μm) was positioned over every PHH3/MART1-posi-
tive cell. Within the circle, the value 1 was added, and out-
side the circle, 0 was added. The hot-spot center was then
defined as the pixel position with most circle overlaps,
which returns the highest summation or intensity value.
This point was encompassed by a 1-mm2 square (Fig. 1h
and i). Epidermal regions and skin adnexa were manually
omitted, if necessary. Only the hottest hot spot was
selected; however, more than one hot spot can, in theory,
occur. Numerical outcome of such should, nevertheless,
be identical or almost identical (minor regions may be
subtracted from the 1-mm2 reference area) when merely
reporting the number per square.
Index calculations
MART1-adjusted indices were defined as the number of
PHH3/MART1-positive cells divided by the MART1-
verified tumor area including nuclei within the outlined
global tumor area (Fig. 1d and e) and a hot spot. Hot-
spot indices were also reported as merely the number
within the hot-spot square.
Statistical analyses
Stata 12.0 (StataCorp, College Station, TX, USA) per-
formed analyses where two-sided P-values less than 0.050
were considered statistically significant.
Bland-Altman plots and Wilcoxon signed-rank tests
compared manual and automated procedures. Paired t
tests compared the location (x and y coordinates) of
hot-spot centroids in image. In addition, the frequency
of manual and automated hot spots that overlapped
was established based on the distances between both
the x and y coordinates of the square centers (see
Fig. 2). The degree of overlap was divided into the
categories: perfect overlap (distances, < 0.10 mm), mayor
overlap (distances, 0.10–0.74 mm), minor overlap (dis-
tances, 0.75–1.0 mm), and no overlap (distances, > l.0 mm).
Univariate and multivariate analyses were performed
using the Cox proportional hazards model. The group
with low PHH3 was the reference group. The multivari-
ate model included the index categorized by its median,
the Breslow thickness (log-transformed), and ulceration.
Time to recurrent disease was calculated from the time
of diagnosis, and patients who either were alive without
recurrence at last clinical follow-up or died without evi-
dence of melanoma were censored.
Results
Global manual and automated PHH3 counts are com-
pared in Fig. 3a, and their ability to detect PHH3/
MART1 positivity is outlined in Table 2. The Spearman
correlation coefficient was 0.77 (P < 0.0010).
The automated counts of the manually and automatic-
ally selected hot spots in cases with coinciding PHH3/
MART1 positivity (n = 92) are compared in Fig. 3b. The
Spearman correlation coefficient was 0.86 (P < 0.0010).
The mean difference between x coordinates of the
manual and automated hot-spot selection was 0.058 mm
(95 % CI, -0.30–0.42 mm, P = 0.75) and -0.31 mm (95 %
CI, -0.62–0.0060 mm, P = 0.054) for y coordinates. Coor-
dinates of the hot-spot centroids were perfectly identical
in 22 cases (24 %), with mayor overlap in 35 cases
(38 %), with minor overlap in five cases (5 %), and with-
out overlap in 30 cases (33 %).
The prognostic ability of the different PHH3 quantifi-
cation types is displayed in Table 3 for univariate ana-
lysis and in Table 4 for multivariate analysis. The ability
to detect recurrent disease is outlined in Table 5 for fully
manual and fully automated hot spots.
Discussion
The principle finding of the study was that automated and
manual results were very comparable for both counting
cells and selecting hot spots. The prognostic impact of au-
tomated quantification in the clinically preferred hot spot
was, however, noticeably reduced compared with manual
quantification. Algorithms may, nevertheless, still serve as
valuable tools for pathologists, and the hot-spot detection
seems easily addable to other malignancies and stains.
Although automated indices, in general, were systematic-
ally higher than manual indices, global counts of PHH3/
MART1-positive cells were remarkably comparative in
most cases (Fig. 3a, Table 2), and their prognostic impact
were, accordingly, in fairly the same range (Tables 3 and 4).
Only 33 cell counts (22 %) differed with more than five
cells per mm2. They were primarily lesions with a very
small MART1-verified tumor area (median, 0.39 mm2);
hence, the misinterpretation of a single cell may alter the
calculated index substantially. This was the case for 12
lesions where absolute counts actually only differed with
one to four cells. In the remainder of cases, the automated
algorithm was unsuccessful because of overlaying PHH3-
positive lymphocytes (n = 7; Fig. 4a and b), heavy
pigmentation (n = 6; Fig. 4c and d), pale MART1 (n = 5;
Fig. 4e and f), or very dark MART1 that overlap pixel in-
tensities of PHH3 (n = 3; Fig. 4g and h).




Fig. 2 Categorical comparison of manual and automated hot spots. a Sketched examples of the 1-mm2 hot spots of each method (hatched or
unhatched squares) within the four categories: 1. Perfect overlap; 2. Mayor overlap; 3. Minor overlap; 4. No overlap. Categorization was based on
absolute distances between the center coordinates of the two squares, that is, |Δx| and |Δy|. b Display of minor overlap of manual and automated
hot spots in melanoma with MART1-verified tumor area of 4.80 mm2
Fig. 3 Comparison of the manual and automated index (a) and hot-spot selection (b). a Bland-Altman plot of manual and automated PHH3
counts in the global MART1-verified tumor area; three outliers with differences of -332, -125, and 259 cells/mm2 were excluded. b Bland-Altman
plot of automated PHH3 counts in manually and automatically selected hot spots; two outliers with differences of -21 and 40 cells were excluded.
In both plots, indices of manual procedures are subtracted from automated procedures. Mean difference between indices (d ), 95 % limits of
agreement (LIM), and P-value of Wilcoxon signed rank tests are shown
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Only a few other groups have presented an automated
quantification of PHH3, but without our improved ac-
curacy of immunohistochemical double staining [11, 15,
16, 22, 23]. Even fewer have compared their automated
and manual cell counts [11, 15, 16], and apparently the
actual agreement of methods remains unreported [17].
In a study of melanoma, the association between manual
and automated counts was strong by Pearson’s correlation,
and their prognostic impact comparable; however, the
difference between mean counts seems large (approx. 6/
mm2 for manual counts vs. 16/mm2 for automated
counts) [11]. Our numbers were in the same range (7/
mm2 vs. 10/mm2), but the mean difference considerably
smaller. Previous automation of Ki67/MART1 stains has
demonstrated usefulness in both diagnosis and prognosis
of melanoma [10, 24, 25], but fundamental differences
between stains exclude extrapolation of results. The Ki67/
MART-positive cells are very abundant, which elevates
cut-off point, and cells are mostly circular because they
often are in the G1, S, or G2 phases rather than mitosis.
This eases image analysis because algorithms that enhance
circular structures may be utilized [25].
Because the prognostic impact of hot spots seems
highly superior to global analysis [10] (Tables 3 and 4),
an automated selection was developed. The fully auto-
mated and fully manual selection was very similar, and
hot spots overlapped in most cases (67 %). In cases with-
out overlap (n = 30), manual and automated cell counts
were often in the same range (only nine differed
with more than five cells). After reevaluation of these
nine cases, mistakes pertained to heavy pigmentation
(n = 5), overlaying PHH3-positive lymphocytes (n = 2),
pale MART1 (n = 1), and general failure of the algorithm’s
cluster circles to depict the correct hot spot (n = 1). After
the manual and automated hot-spot selection, an auto-
mated count was performed for both hot-spot types. The
automated algorithm selects the hot spot with cluster
circles based on labels of the preceding automated image
analysis. If correctly selected, the subsequent automated
count of the automatically selected hot spot should always
be higher or equal to the automated count of the manually
selected hot spot. This was the case in 65 of 92 lesions
(71 %; Fig. 3b). In the remainder cases, the cluster circles
failed because another hotter hot spot actually existed.
Yet, the difference between counts was very small
(median, three cells per hot spot), and most hot spots
actually still overlapped (n = 19). Nevertheless, few er-
rors must be expected in automated hot-spot selec-
tion, which mostly pertains to the chosen radius of the
cluster circles. Underlining their comparability, the
prognostic performance of the manual and automated
selection was very alike (Tables 3 and 4). No distinct
parallel was observed between lesion size and hot-spot
overlap, but hot spots were of course more likely to
completely overlap in very small lesions. The mean
MART1-verified tumor area was 2.69 mm2 (range,
0.020–50 mm2) for the entire cohort.
Because no previous study has developed or evaluated
automated hot-spot selection in PHH3 stains or evaluated
the currently presented algorithms for Ki67 stains [18–20]
in a clinical setting, studies supporting our comparability
of manual and automated selection are warranted.
It has previously been established that the global
MART1-verified tumor area is preferable to simply using
the area within the global outline, which includes
surrounding stroma, as reference space in melanoma
diagnosis (Fig. 1d vs. Fig. 1f ) [24], and this was also the
case for prognostic purposes in this study (data not
shown). This is possibly explained by lesional dependent
amounts of stromal tissue that also may vary according
to the subjective outline of the observer. Surprisingly,
the MART1-adjusted hot spot of manual counts
was quite inferior to just reporting the number of
Table 3 Univariate Cox regression analysis
PHH3 quantification type with index categorized by median Progression-free survival
HR 95 % CI P
Manual count & outline, hot spot, 0 vs. ≥ 1.0 14 3.4 - 58 > 0.0010
Manual count & outline, MART1-adjusted hot spot, ≤ 7.7/mm2 vs. > 7.7/mm2 6.1 2.7 - 14 > 0.0010
Manual count & outline, MART1-adjusted global, ≤ 3.3/mm2 vs. > 3.3/mm2 4.3 2.1 - 9.0 > 0.0010
Automated count & manual outline, hot spot, 0 vs. ≥ 1.0 3.4 1.7 - 6.8 > 0.0010
Automated count & outline, hot spot, ≤ 2.0 vs. > 2.0 3.8 2.0 - 7.1 > 0.0010
Automated count & outline, MART1-adjusted hot spot, ≤ 14/mm2 vs. > 14/mm2 3.3 1.6 - 6.5 0.0010
Automated count & manual outline, MART1-adjusted global, ≤ 4.0/mm2 vs. > 4.0/mm2 2.5 1.3 - 4.9 0.0060
Abbreviations: PHH3 phosphohistone H3, HR hazard ratio, CI confidence interval
Table 2 Comparison of manual and automated detection of
PHH3/MART1-positive cells
Automated, no. (%) Total, no. (%)
Count = 0 Count≥ 1
Manual, no. (%) Count = 0 41 (27) 14 (9) 55 (36)
Count ≥ 1 6 (4) 92 (60) 98 (64)
Total, no. (%) 47 (31) 106 (69) 153 (100)
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PHH3/MART1-positive cells within the square (Tables 3
and 4); hence, cellular density seems of less import-
ance in melanoma hot-spot analysis compared with
global analysis. The result may, however, just reflect
the fact that an overall division into PHH3-positive
and PHH3-negative patients is more important for
prognostic purposes.
Despite our concordance between manual and auto-
mated indices and hot spots, the prognostic impact of
automated quantification in a hot spot was noticeably
reduced compared with the fully manual quantification
(Tables 3 and 4). This is possibly because of the study’s
low cut-off point (one cell per square for fully manual
hot spots), which divides the cases into either PHH3-
positive or PHH3-negative; hence, misinterpretation of
only one cell is of grave importance in the cases with no
vs one PHH3/MART1-positive cell (n = 68). High sensi-
tivity and specificity of both manual and automated ana-
lysis is thus required. Because the manual count was
gold standard, all lesions were very carefully examined
by virtual microscopy, many repeatedly, and one could
speculate whether some mitoses would have been left
undetected in a routine setting with a heavy workload.
In automated analysis, similar high performance is diffi-
cult to achieve because a few errors inevitable will occur
(Fig. 4). Primarily, it seems difficult to prevent false-
positive counts of PHH3-positive non-melanocytic cells
or brown pigment surrounded by MART1 and false-
negative counts of tumor cells that express no or only
sparse MART1 (Fig. 4a-f). In addition, proper recognition
of PHH3/MART1-positive cells seems especially difficult
because the shape of PHH3-positive nuclei changes
throughout mitosis, and MART1 has a tendency to be-
come pale and sometimes almost white around the nuclei
(Fig. 1c) for unknown reasons. Furthermore, the anaphase
and telophase may also occasionally be overlooked or
regarded as two rather than just one cell (Fig. 4i and j),
even though an algorithm may be designed to fuse the
chromatin into one object. Inevitably, staining quality also
changes despite standardization. The inability of algo-
rithms to deal with variations in staining color and inten-
sity between and within sections is, in general, a mayor
drawback of digital image analysis. An algorithm that nor-
malizes signals of immunohistochemical stains, e.g., by
control sections, is thus highly needed. Other chromo-
genes than DAB or the use of virtual double stains could,
in addition, be explored to enhance the results of auto-
mated image analysis in melanoma.
Still, all our lesions were analyzed with the same
fixed protocol; hence, manual review with alteration of
algorithms or rejection of result may possibly improve
prognostic impact noticeably, and this is possibly a
general necessity in the establishment of diagnostic
digital pathology.
Though the prognostic impact of our fully automated
quantification of PHH3 in hot spots diminished, algo-
rithms may still serve as valuable tools for the pathologist.
Adhering to the current staging manual where presence of
Table 5 Diagnostic performance of fully manual and fully automated hot-spot quantification
Manual hot spot (cut-off, 1 cell per square) Automated hot spot (cut-off, 2 cells per square)
95 % CI 95 % CI
Sensitivity, % 95 84 - 99 67 52 - 81
Specificity, % 48 39 - 58 71 62 - 79
ROC area 0.83 0.76 - 0.90 0.74 0.65 - 0.83
Positive predictive value, % 42 32 - 52 48 35 - 61
Negative predictive value, % 96 88 - 100 85 76 - 91
Abbreviations: ROC receiver-operating characteristic, CI confidence interval
Table 4 Multivariate Cox regression analysis including Breslow thickness (continuous, log-transformed) and ulceration
PHH3 quantification type with index categorized by median Progression-free survival
HR 95 % CI P
Manual count & outline, hot spot, 0 vs. ≥ 1.0 5.5 1.3 - 24 0.024
Manual count & outline, MART1-adjusted hot spot, ≤ 7.7/mm2 vs. > 7.7/mm2 3.0 1.2 - 7.1 0.015
Manual count & outline, MART1-adjusted global, ≤ 3.3/mm2 vs. > 3.3/mm2 1.9 0.82 - 4.3 0.14
Automated count & manual outline, hot spot, 0 vs. ≥ 1.0 1.9 0.92 - 3.8 0.085
Automated count & outline, hot spot, ≤ 2.0 vs. > 2.0 1.3 0.61 - 2.9 0.47
Automated count & outline, MART1-adjusted hot spot, ≤ 14/mm2 vs. > 14/mm2 1.7 0.81 - 3.7 0.16
Automated count & manual outline, MART1-adjusted global, ≤ 4.0/mm2 vs. > 4.0/mm2 1.3 0.62 - 2.7 0.49
NOTE. Only patients with a classified Breslow thickness were included (n = 144). Thus, the number of events was reduced to 39.
Abbreviations: PHH3 phosphohistone H3, HR hazard ratio, CI confidence interval
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a single H&E mitosis alters the tumor category and hence-
forth the subsequent surgical procedures (sentinel lymph
node biopsy) in thin melanoma, recognition of one
PHH3/MART1-positive cell is important. Although PHH3
highlights mitotic figures substantially compared with
H&E, careful and time-consuming screening may still fre-
quently be needed. Given its high sensitivity, the labels or
heat map of the global index quantification may vividly
direct the observer’s attention to cells that are most likely
in mitosis, and the risk of overlooking that single mitotic
cell may possibly be reduced. Furthermore, automated
analysis with automated hot-spot selection may prove very
useful in other malignancies or stains with higher clinical
cut-off points than melanoma. For instance, in early breast
cancer, a PHH3 cut off of 13 cells per 1.8 mm2 has been
proposed to distinguish high and low risk patients [15],
and a Ki67 index above 30 % was recently acknowledged
as an indicator for adjuvant chemotherapy [26]. In
addition, neuroendocrine tumors are divided into well- or
poorly differentiated by a Ki67 cut off of 20 % or a
hematoxylin-eosin mitotic index of 20 mitoses per 2 mm2;
however, the suggested cut offs for PHH3 are as low as
four cells per 2 mm2 [27].
Conclusions
In conclusion, manual detection of PHH3/MART1-posi-
tivity in a 1-mm2 hot spot yielded an outstanding prog-
nostic performance in our study of stage I/II melanoma;
however, adjusting the reference space for tumor cellular-
ity and automation of quantification reduced its prognos-
tic impact noticeably. The automated index quantification
and automated hot-spot selection were, nevertheless, very
comparable to their manual counterpart. The automated
results may thus still aid and improve the pathologist’s
detection of mitoses in melanoma and possibly be useful
in other malignancies and future research studies. Differ-
entiation into merely PHH3/MART1-positive or PHH3/
MART1-negative cases was ideal for prognostic purposes
in our cohort, but further studies are warranted to estab-







Fig. 4 Errors of automated PHH3/MART1 image analysis in five different
melanomas. a Three PHH3-positive non-melanocytic cells (possibly
lymphocytes) that overlay or are in close connection to MART1.
b They are thus falsely counted as PHH3/MART1-positive cells.
c Brown pigment embedded in or in close connection to MART1.
d False-positive counts consequently occur. e Very pale MART1 stain of
melanocytic cells. f A PHH3-positive mitosis is thus overlooked. g Very
dark MART1 stain or artifact that resembles pixel intensities of brown
staining. h Because shape, in addition, resembles a nucleus, a false-
positive count is made. i Telophase of PHH3/MART1-positive cell.
j Distance between chromatin of dividing nucleus is too large to
fuse them into one object with the post-processing step dilation,
and this mitosis is therefore overlooked
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